Skip to content
BAX Baxter International Inc NYSE
41.97 USD 1.52% +0.63
OPEN 41.54
DAY RANGE 42.22 - 41.24
52 WEEK RANGE 73.63 - 37.35
Interactive Brokers Logotype

Buy BAX stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 21.2B
Enterprise value 36.5B
Trailing pe -8.6894409937888
Forward pe 12.603604
Peg ratio 12.603604
Price to sales ttm 1.4101976
Price to book mrq 3.6112547
Enterprise to revenue 2.425
Enterprise to ebitda 11.8


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin -0.1634
Operating margin 0.11637
Return on assets ttm 0.0359
Return on equity ttm -0.32523
Income statement
Revenue ttm 15.1B
Revenue per share ttm 29.841
Quarterly revenue growth -0.016
Gross profit ttm 6B
Ebitda 1.5B
Net income to common ttm -2460000000
Diluted eps ttm -4.79
Quarterly earnings growth yoy -0.38
Balance sheet
Total cash mrq 1.7B
Total cash per share mrq 3.307
Total debt mrq 16.9B
Total debt to equity mrq 284.279
Current ratio mrq 1.701
Book value per share mrq 11.622
Cash flow
Operating cash flow ttm 1.5B
Levered free cash flow ttm 1.2B

Stock statistics

Shares outstanding 505.8M
Float shares 504.1M
Avg 10 volume 5.1M
Avg 30 volume 4.9M
Shares short 5.7M
Short ratio 0.94
Short percent of shares outstanding 0.0125
Percent held by insiders 0.00243
Percent held by institutions 0.83986

Stock price summary

Fifty two week low 37.35
Fifty two week high 72.65
Fifty two week change -70.527
Beta 0.564743
Day 50 ma 43.1192
Day 200 ma 48.1409

Dividends and splits

Forward annual dividend rate 1.16
Forward annual dividend yield 0.028299998
Trailing annual dividend rate 1.16
Trailing annual dividend yield 0.02805999
5 year average dividend yield 1.36
Dividend date 2023-07-03
Ex dividend date 2023-06-01
Last split factor 1841-for-1000 split
Last split date 2015-07-01

Baxter International (BAX) company profile

Baxter International Inc. (NYSE: BAX) is a healthcare company that provides a portfolio of essential products. Its products include renal care, medication delivery, pharmaceuticals, clinical nutrition, advanced surgery and acute therapies. Baxter sells its products through a direct sales force alongside independent distributors in about 100 countries.